ESR1 and breast carcinoma: CXCR4 is the receptor for the chemokine SDF-1, is important in the metastatic potential of estrogen receptor positive ovarian and breast cancer [37,38] and is linked to poor prognosis in a variety of tumor types and leukemias [39-41].